Labcorp Holdings Inc. (LH)
Labcorp Holdings Inc. (LH) Current vs Average EV/EBITDA Ratio
How Labcorp Holdings Inc. (LH)'s current ev/ebitda ratio of 13.73x compares to its TTM/3Y/5Y/10Y/15Y/20Y averages as of Sunday, June 14, 2026.
Current vs Average EV/EBITDA Ratio Chart
LH EV/EBITDA Ratio vs Average
CURRENT VS TTM AVG
-6.52%
CURRENT VS 3Y AVG
-5.85%
CURRENT VS 5Y AVG
+17.21%
CURRENT VS 10Y AVG
+22.21%
CURRENT VS 15Y AVG
+30.77%
CURRENT VS 20Y AVG
+36.46%
About Labcorp Holdings Inc.
Labcorp Holdings, Inc. offers vital diagnostic laboratory services, enabling medical professionals, healthcare facilities, pharmaceutical firms, scientific investigators, and patients to make well-informed and confident choices. The company commenced operations on April 16, 2024, and its main office is situated in Burlington, NC.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Adam H. Schechter